OCT 22, 2019 10:34 PM PDT

Using senolytics to treat cancer

New research published in Nature Metabolism proposes using an already existing drug – a cardiac glycoside called ouabain – as a senolytic to kill off damaged aging or cancerous cells. Senolytics are a class of drugs that are capable of selectively killing senescent cells, or cells that have reached their natural aging process. Although senescence is normal, previous studies have shown that senescent cells can contribute to the spread and growth of cancer tumors.

While past research has identified some senolytics with potential anti-cancer properties, those tested up until now have also had serious side effects. However, the researchers behind the new study believe that ouabain may offer a safer alternative broad-spectrum senolytic, capable of targeting a varied array of aging cells. The research team hails from the MRC London Institute of Medical Sciences in the United Kingdom.

Senior author Professor Jesús Gil commented on the potential of ouabain, saying "These drugs are already used in the clinic, so they could be repurposed to treat a long list of diseases, including cancer. This is something we are keen to explore with our clinical collaborators. Moreover, many patients are being treated with digoxin, and an epidemiologist could look retrospectively and ask the question of whether those patients who were treated with digoxin are doing better than those who weren't."

Digoxin is another type of cardiac glycoside and is in the same class of drugs as ouabain. These drugs are usually prescribed to treat cardiac arrhythmias and atrial fibrillation; however, when the researchers experimented with them to see how they affect healthy and senescent cells, they discovered that ouabain, in particular, is capable of selectively killing aging cells.

In the study, which was conducted in aging mice with precancerous lesions in the liver and after radiotherapy, the team found that ouabain was successful in killing cells senescent from cancer as well as those senescent from exposure to radiotherapy or chemotherapy.

The authors say that future studies should continue to consider the potential of cardiac glycosides as senolytics in cancer treatments. They hope to continue their investigations in this field.

Sources: Nature Metabolism, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
MAR 29, 2021
Cancer
Modeling metastasis
MAR 29, 2021
Modeling metastasis
Novel research published in Genome Biology investigates the cellular mechanisms at work during cancer metastasis using n ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
MAY 27, 2021
Cancer
Which ovarian cancer patients will be resistant to platinum chemotherapy?
MAY 27, 2021
Which ovarian cancer patients will be resistant to platinum chemotherapy?
Research published in the journal EMBO Molecular Medicine details a novel mechanism that can be used to predict which ep ...
MAY 28, 2021
Cancer
Does your birth control increase your risk of breast cancer?
MAY 28, 2021
Does your birth control increase your risk of breast cancer?
A study published recently in EMBO Molecular Medicine considers the biological impacts of progestins from hormonal contr ...
JUN 08, 2021
Immunology
Fueling the Immune System's Killers
JUN 08, 2021
Fueling the Immune System's Killers
There’s a group of “killers” protecting your body against infections and eliminating potentially cance ...
Loading Comments...